1. Home
  2. SUNS vs ELTX Comparison

SUNS vs ELTX Comparison

Compare SUNS & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUNS
  • ELTX
  • Stock Information
  • Founded
  • SUNS 2023
  • ELTX 2011
  • Country
  • SUNS United States
  • ELTX United States
  • Employees
  • SUNS N/A
  • ELTX N/A
  • Industry
  • SUNS Real Estate Investment Trusts
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SUNS Real Estate
  • ELTX Health Care
  • Exchange
  • SUNS Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • SUNS 148.0M
  • ELTX 121.7M
  • IPO Year
  • SUNS N/A
  • ELTX N/A
  • Fundamental
  • Price
  • SUNS $11.67
  • ELTX $11.50
  • Analyst Decision
  • SUNS Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • SUNS 3
  • ELTX 2
  • Target Price
  • SUNS $13.58
  • ELTX $11.00
  • AVG Volume (30 Days)
  • SUNS 50.5K
  • ELTX 101.1K
  • Earning Date
  • SUNS 11-06-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • SUNS 10.53%
  • ELTX N/A
  • EPS Growth
  • SUNS N/A
  • ELTX N/A
  • EPS
  • SUNS 1.04
  • ELTX N/A
  • Revenue
  • SUNS $16,359,932.00
  • ELTX N/A
  • Revenue This Year
  • SUNS $183.25
  • ELTX N/A
  • Revenue Next Year
  • SUNS $62.46
  • ELTX N/A
  • P/E Ratio
  • SUNS $10.93
  • ELTX N/A
  • Revenue Growth
  • SUNS 1342.10
  • ELTX N/A
  • 52 Week Low
  • SUNS $7.80
  • ELTX $4.05
  • 52 Week High
  • SUNS $15.74
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • SUNS 67.80
  • ELTX 56.79
  • Support Level
  • SUNS $11.00
  • ELTX $10.00
  • Resistance Level
  • SUNS $11.36
  • ELTX $12.62
  • Average True Range (ATR)
  • SUNS 0.27
  • ELTX 0.74
  • MACD
  • SUNS 0.04
  • ELTX -0.04
  • Stochastic Oscillator
  • SUNS 97.30
  • ELTX 57.25

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: